Alacris Theranostics GmbH
About Alacris Theranostics
Alacris Theranostics (www.alacris.de) is a company based in Berlin specialized in developing new approaches in personalized medicine for cancer patient diagnosis, treatment and drug stratification. Alacris Theranostics is applying a systems biology approach exclusively licensed as ModCellTM to Alacris. Based on genome and transcriptome information obtained by next generation sequencing and including kinetic pathway information, mutation and drug databases, the systems biology approach is providing a "Virtual Patient" model. The “Virtual Patient” model can predict the effect of drug treatment and optimized combinatory treatment providing means for truly personalized medicine approaches. In addition, Alacris' "Virtual Clinical Trials" system permits the in silico analysis of drugs, thus identifying stratified patient groups with particular genetic and molecular profiles that could be targeted by the drug, with the goal of more efficient drug development and approval.